Player FM 앱으로 오프라인으로 전환하세요!
Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation
Manage episode 384303520 series 2286865
Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD.
Explore the compelling journey from oncology to ophthalmology, unraveling strategic decisions, navigating competitive landscapes, and achieving triumphs in clinical trials. Dr. Baldwin unfolds her remarkable career trajectory, from a PhD at the University of Melbourne to pivotal roles at Genentech and the Ludwig Institute for Cancer Research.
Tune in for exclusive insights, including:
- Opthea's strategic approach to revolutionizing eye care
- Clinical Trials: A deep dive into their success and impact
- Comparison with Other Drugs: Differentiating factors and unique contributions
- Future Directions: Exploring new horizons and clinical opportunities
- Commercialization Timeline: Anticipated milestones and FDA approval strategies
Listen now for a compelling journey through Opthea's vision as they continue to shape the landscape of ophthalmological advancements.
Opthea: Opthea.com
Megan Baldwin, PhD: LinkedIn
Firas Rahal, MD ois.net/robert-rothman-md
398 에피소드
Manage episode 384303520 series 2286865
Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD.
Explore the compelling journey from oncology to ophthalmology, unraveling strategic decisions, navigating competitive landscapes, and achieving triumphs in clinical trials. Dr. Baldwin unfolds her remarkable career trajectory, from a PhD at the University of Melbourne to pivotal roles at Genentech and the Ludwig Institute for Cancer Research.
Tune in for exclusive insights, including:
- Opthea's strategic approach to revolutionizing eye care
- Clinical Trials: A deep dive into their success and impact
- Comparison with Other Drugs: Differentiating factors and unique contributions
- Future Directions: Exploring new horizons and clinical opportunities
- Commercialization Timeline: Anticipated milestones and FDA approval strategies
Listen now for a compelling journey through Opthea's vision as they continue to shape the landscape of ophthalmological advancements.
Opthea: Opthea.com
Megan Baldwin, PhD: LinkedIn
Firas Rahal, MD ois.net/robert-rothman-md
398 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.